Robert Carr, Chairman and CEO of In Silico Biosciences, Inc. presenting the ISB competitive advantage of disease system modeling at the Centre for Human Drug Research, December 6-8, 2023, during the QSPainRelief 5th General Assembly & Patient Event, held in Leiden, The Netherlands.